Tilmovet 100 mg/g oral granules for pigs

Země: Irsko

Jazyk: angličtina

Zdroj: HPRA (Health Products Regulatory Authority)

Aktivní složka:

Tilmicosin

Dostupné s:

Huvepharma NV

ATC kód:

QJ01FA91

INN (Mezinárodní Name):

Tilmicosin

Dávkování:

100 milligram(s)/gram

Léková forma:

Granules

Druh předpisu:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeutické skupiny:

Porcine

Terapeutické oblasti:

tilmicosin

Terapeutické indikace:

Antibacterial

Stav Autorizace:

Authorised

Datum autorizace:

2009-11-06

Charakteristika produktu

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Tilmovet 100 mg/g oral granules for pigs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
ACIVE SUBSTANCE:
Tilmicosin: 100 mg
EXCIPIENTS
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral granules.
A brown granulated powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (weaned piglets and fattening pigs).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is indicated for the treatment of pneumonia in weaned
piglets and fattening pigs, caused by_ Actinobacillus_
_pleuropneumoniae, Mycoplasma hyopneumoniae, Pasteurella multocida_
sensitive to tilmicosin.
4.3 CONTRAINDICATIONS
Do not use in animals hypersensitive to tilmicosin and when there is
resistance to tilmicosin or cross resistance to other
macrolides like tylosin, erythromycin or lincomycin.
Tilmicosin is known to be toxic for horses. Do not allow horses or
other equines access to feeds containing tilmicosin.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
If for an individual animal, feed intake is such that the recommended
dosage is not realised, medication should be
carried out by parenteral treatment.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_1_
_/_
_0_
_8_
_/_
_2_
_0_
_1_
_4_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_7_
_0_
_6_
_5_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Cross-resistance between tilmico